Cefdinir (Omnicef)

A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin.

Also Known As:

Omnicef; 7-(2 (2-Aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid; CI 983; CI-983; FK 482; FK-482; PD 134393; PD-134393; CI983; FK482; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)-1-oxoethyl)amino)-3-ethenyl-8-oxo-, (6R,7R)-

Networked: 131 relevant articles (27 outcomes, 37 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Nemeth, M A: 7 articles (12/2000 - 01/2000)
2.	Tack, K J: 7 articles (12/2000 - 01/2000)
3.	Brook, Itzhak: 6 articles (05/2009 - 07/2004)
4.	Block, Stan L: 5 articles (10/2012 - 10/2003)
5.	Jones, Ronald N: 5 articles (02/2007 - 11/2003)
6.	Sader, Helio S: 5 articles (02/2007 - 11/2003)
7.	Keyserling, C H: 5 articles (12/2000 - 01/2000)
8.	Busman, Todd A: 4 articles (12/2006 - 09/2004)
9.	Paris, Maria M: 4 articles (06/2005 - 01/2004)
10.	Prajapati, Bhumika: 3 articles (01/2019 - 04/2014)

Related Diseases

1.	Infections 02/01/2015 - "Given these preliminary results, a fully powered study is warranted to explore the efficacy of cefdinir as a therapeutic tool for new-onset pediatric neuropsychiatric symptoms, particularly those that appear to be precipitated by infection." 04/01/1997 - "Cefdinir appears to be an effective and well-tolerated agent for the treatment of uncomplicated skin and skin structure infections in pediatric patients." 10/01/1990 - "We have concluded that cefdinir is useful in the treatment of infection in the pediatric field." 03/01/1998 - "The Cefdinir Adult Skin Infection Study Group." 04/01/1997 - "The Cefdinir Pediatric Skin Infection Study Group."
2.	Pharyngitis (Sore Throat) 11/01/1999 - "This multicenter, randomized, controlled, double-masked study assessed the tolerability and efficacy of 2 dosing regimens of cefdinir in the treatment of pharyngitis due to GABHS. " 11/01/1999 - "Cefdinir Pharyngitis Study Group." 09/01/1999 - "This multicenter, randomized, controlled, investigator-masked study was performed to assess the efficacy and tolerability of cefdinir for the treatment of streptococcal pharyngitis. " 05/01/1998 - "Cefdinir Pharyngitis Study Group." 01/01/1997 - "Cefdinir Pediatric Pharyngitis Study Group."
3.	Pneumonia (Pneumonitis) 11/17/2004 - "cefdinir is safe and effective, shorten the course of treatment in the treatment of mild to moderate bacterial community acquired pneumonia." 07/01/1997 - "These results indicate that cefdinir is effective and safe in the treatment of patients with pneumonia." 11/17/2004 - "To evaluate the efficacy and safety of cefdinir in the treatment of patients with mild to moderate bacterial community acquired pneumonia (CAP). " 10/01/2001 - "Twice-daily administration is likely the more appropriate cefdinir dosing strategy for the treatment of community-acquired pneumonia." 07/01/1997 - "Six hundred ninety patients were enrolled in a multicenter, randomized, double-blind trial comparing the efficacy and safety of cefdinir with those of cefaclor in the treatment of community-acquired pneumonia. "
4.	Chronic Bronchitis 06/01/2000 - "These results indicate that a five-day regimen of cefdinir is effective and safe for the treatment of patients with acute exacerbations of chronic bronchitis." 06/01/2000 - "To compare the efficacy and safety of five-day cefdinir treatment with seven-day loracarbef treatment in patients with acute exacerbations of chronic bronchitis, 586 patients were enrolled in a multicentre, randomised, double-blind trial. " 06/01/2000 - "Patients with acute exacerbations of chronic bronchitis were treated with cefdinir 300 mg bd for 5 days or cefprozil 500 mg bd for 10 days in a prospective, randomized, double-blind, multicentre study. " 01/01/2000 - "International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis." 06/01/2000 - "A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis."
5.	Otitis Media 05/01/2008 - "Three weeks later, he again received cefdinir for recurrent otitis media. " 12/01/2000 - "To examine the microbiologic and clinical efficacy of a 5-day course of cefdinir in the treatment of tympanocentesis-documented acute otitis media (AOM). " 12/01/2000 - "Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy." 03/01/2006 - "A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection." 03/01/2006 - "Because the current cefdinir dosage of 14 mg/kg/d is approved for treatment of acute otitis media caused by penicillin-susceptible Streptococcus pneumoniae, we hypothesized that a 25-mg/kg dose given daily would be more effective for nonsusceptible S. "

Related Drugs and Biologics

1.	Amoxicillin (Wymox)
2.	Penicillin V (Phenoxymethylpenicillin)
3.	Clavulanic Acid (Potassium Clavulanate)
4.	Cefprozil (Cefzil)
5.	Penicillins (Penicillin)
6.	Cefdinir (Omnicef)
7.	Cefpodoxime Proxetil (Vantin)
8.	cefditoren pivoxil (Spectracef)
9.	cefteram pivoxil
10.	CS 834

Related Therapies and Procedures

1.	Therapeutics
2.	Renal Dialysis (Hemodialysis)
3.	Debridement
4.	Oral Administration
5.	Catheters